InvestorsHub Logo
icon url

Pharmacydude

12/16/22 10:20 AM

#395910 RE: IgnoranceIsBliss #395904

TTE
IIRC from calculations I did 6-9 months ago, Amarin was making a net revenue (after rebates, discount cards, incentives etc) of about $125/bottle at a cost of about $30/bottle. Profit of around $95/bottle. I believe Capt has more current/accurate data. My GUESS would be that with 3 generics now competing against Amarin and against each other, gV probably nets $90/bottle at a cost of $40 for a profit of $50/bottle.
Just my best guess
One problem (of many) with my settlement idea is that other insurance companies that committed to Amarin as their supplier may have included a clause that they would receive the lowest cost Amarin offered to other insurers (ie: lowest price guarantee). Would this settlement force Amarin to lower their prices to others?